BSE Live
Sep 30, 16:01Prev. Close
405.60
Open Price
405.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 30, 15:43Prev. Close
406.05
Open Price
404.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | |
Total Share Capital | 6.13 | 12.12 | 11.11 | 10.27 | 9.57 | |
Reserves and Surplus | 307.84 | 301.36 | 297.87 | 387.32 | 480.39 | |
Total Reserves and Surplus | 307.84 | 301.36 | 297.87 | 387.32 | 480.39 | |
Total Shareholders Funds | 313.97 | 313.48 | 308.98 | 397.59 | 489.96 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 160.51 | 118.87 | 97.41 | 79.96 | 58.63 | |
Deferred Tax Liabilities [Net] | 13.98 | 24.79 | 24.79 | 0.00 | 0.00 | |
Other Long Term Liabilities | 9.65 | 10.03 | 5.42 | 2.58 | 8.15 | |
Long Term Provisions | 19.95 | 15.82 | 12.70 | 13.30 | 12.37 | |
Total Non-Current Liabilities | 204.09 | 169.52 | 140.32 | 95.84 | 79.15 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 67.94 | 0.00 | 0.06 | 0.05 | 0.00 | |
Trade Payables | 164.83 | 122.69 | 129.12 | 168.43 | 124.06 | |
Other Current Liabilities | 87.71 | 96.34 | 95.04 | 72.90 | 72.31 | |
Short Term Provisions | 30.93 | 29.97 | 28.74 | 5.38 | 4.44 | |
Total Current Liabilities | 351.41 | 248.99 | 252.95 | 246.76 | 200.80 | |
Total Capital And Liabilities | 869.47 | 753.64 | 723.90 | 761.83 | 791.57 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 447.37 | 357.22 | 385.26 | 416.07 | 397.93 | |
Intangible Assets | 0.57 | 0.04 | 0.06 | 0.06 | 0.51 | |
Capital Work-In-Progress | 87.40 | 70.80 | 16.42 | 0.86 | 12.93 | |
Other Assets | 0.00 | 65.77 | 50.04 | 37.90 | 65.81 | |
Fixed Assets | 535.34 | 519.57 | 463.20 | 454.91 | 477.22 | |
Non-Current Investments | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.35 | 0.08 | 1.15 | |
Other Non-Current Assets | 40.13 | 50.60 | 54.95 | 17.75 | 20.38 | |
Total Non-Current Assets | 575.74 | 570.44 | 518.77 | 473.01 | 499.02 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 152.10 | 107.93 | 116.10 | 129.25 | 87.04 | |
Trade Receivables | 20.85 | 11.08 | 12.27 | 23.32 | 35.29 | |
Cash And Cash Equivalents | 62.16 | 29.44 | 43.25 | 42.69 | 88.96 | |
Short Term Loans And Advances | 1.77 | 2.64 | 0.81 | 0.85 | 1.29 | |
OtherCurrentAssets | 56.85 | 32.11 | 32.71 | 92.72 | 79.97 | |
Total Current Assets | 293.73 | 183.20 | 205.13 | 288.82 | 292.55 | |
Total Assets | 869.47 | 753.64 | 723.90 | 761.83 | 791.57 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 377.08 | 643.19 | 372.80 | 411.92 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 111.44 | 146.82 | 53.89 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 28.95 | 4.10 | 0.88 | 0.15 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 149.92 | 2.62 | 41.46 | 9.55 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 307.06 | 199.23 | 120.53 | 217.64 | |
Other Earnings | -- | 12.48 | -- | 3.03 | 9.33 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | 1.81 | 1.81 | 1.81 | 1.81 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 0.27 | 0.27 | 0.27 | 0.27 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y